Introduction: built-in chromatographic, free of charge payload, and cytotoxicity assays permit precise DAR characterization critical to optimizing Harmless and powerful antibody-drug conjugates in cancer therapy. while in the realm of focused cancer therapies, keeping rigorous quality cri